P110α inhibitor alpelisib exhibits a synergistic effect with pyrotinib and reverses pyrotinib resistant in HER2+ breast cancer

Human epidermal growth factor receptor 2 (HER2) plays a critical role in breast cancer progression in patients with HER2 overexpression, thereby driving the development of targeted drugs and advancing therapy strategies targeting this gene. Pyrotinib is a novel irreversible pan-ErbB kinase inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hao, Si, Yuhao, Wen, Jialiang, Hu, Chunlei, Xia, Erjie, Wang, Yinghao, Wang, Ouchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314290/
https://www.ncbi.nlm.nih.gov/pubmed/37348428
http://dx.doi.org/10.1016/j.neo.2023.100913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314290/
https://www.ncbi.nlm.nih.gov/pubmed/37348428
http://dx.doi.org/10.1016/j.neo.2023.100913

Ejemplares similares